statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The U.S. Federal Trade Commission (FTC) announced last week that it is, for the second time, disputing hundreds of junk patents listed in the Food and Drug Administration's (FDA) Orange Book, a...

The FTC is challenging 'junk' drug patents. Here's what they are and why they matter

Eli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch's heart monitoring tech was approved for use in clinical studies...

Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply

Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments...

Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance

Five Simple Policies To Reset America's "Rigged" Health System

 Calley Means, a one-time consultant for big food and pharmaceutical companies in the Washington, DC, swap and now the...

Five Simple Policies To Reset America's "Rigged" Health System

This is not the first time the tech mogul has seemingly backed the blockbuster drug. Last year, Musk claimed that Ozempic was affecting food sales at Walmart.
read more...

'Ozempic Ftw:' Elon Musk Touts Novo Nordisk's Blockbuster Drug As Solution To Childhood Obesity Problem

Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market...

Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?

If Soranus of Ephesus were alive today he'd be mighty surprised.Like his modern-day counterparts in the medical field, the 2nd Century Greek physician considered obesity to be a disease, and he...

Analyst unveils Amgen stock price target after weight-loss drug data

At least 25,000 Americans are beginning treatment with Novo Nordisk's Wegovy each week and that figure is growing, the company said.The Danish pharmaceutical giant, which has been ramping up...

25K Americans starting Wegovy weekly as supply increases and prices drop, drugmaker says

Here Comes Obesity Drug Competition: Amgen Shares Soar On "Very Encouraging" Clinical Trial Update

 Amgen's shares soared in premarket trading in New York following the drug maker's...

Here Comes Obesity Drug Competition: Amgen Shares Soar On "Very Encouraging" Clinical Trial Update

Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower...

Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Watchers	9,859
52-Wk Low	$75.56
52-Wk High	$138.28

Volume	4.06M
52-Wk High	$138.28
52-Wk Low	$75.56

Period	Estimated	Reported	Surprise	Result
Q2'24	$0.80	--	--	N/A
Q1'24	$0.75	$0.81	8.33%	BEAT
Q4'23	$0.67	$0.72	6.77%	BEAT
Q3'23	$0.68	$0.71	4.58%	BEAT
Q2'23	$0.68	--	--	N/A

NVO Novo Nordisk A/S

About

Feed

News

Sentiment

Earnings

Fundamentals